The Standing Frontier Sweep — RDKG's twice-weekly heartbeat
The metronome of the garden. Where the EdKG → AllowED beat watches one regulated world on a monthly pulse, the Standing Frontier Sweep watches the whole frontier twice a week — the growing tip doing what a meristem does: extending, on a dependable rhythm, into new territory.
The veins. Eight of them, chosen to cover both the meaning gardens and the money gardens: human health & longevity (HKG), AI & the machine layer (TKG / the moat thesis itself), materials & building (BKG), agriculture & robotics (GKG/FKG), and the four commercial veins the founder added — marketing (MktKG), fashion (FshKG), resale goods (ResKG), and crypto & agent-commerce (the x402 / AP2 rails that let verified ground truth be sold to machines).
The loop. Read the lessons → sweep wide for leads → deep-verify the keepers against a primary → card the survivors → log what changed → validate to zero errors → hand the founder the build. Leads (podcasts, news, threads) are candidates only; a card exists once a primary source and a date are attached. When a draft and the primary disagree, the primary wins and the divergence is flagged.
Why a feed, not a one-off. RDKG's whole wager is that verified, freshly-measured ground truth is the scarce input as intelligence collapses toward free. A wager like that has to be restocked on a rhythm, or the freshness — the only thing that makes it defensible — decays. Twice a week is the heartbeat that keeps the moat wet.
Cadence honesty. "Verified" always means verified as of a date. A card that has not been re-checked past its freshness window is a candidate for re-verification on the next sweep, not a permanent truth. Sources that go dark are flagged, not silently dropped.
Findings
— 68 filedSix 2027 I-Codes are live in ICC's own catalogue — the three flagship codes trade press said were 'anticipated in September 2026' are not, as read on 22 September (ICC Digital Codes)
Trade press (NAHB, 27 Aug 2026) reported the 2027 IBC, IFC and IWUIC were 'anticipated in September 2026.' Read directly in ICC's own Digital Codes c…
EMA calls Pebrilzo the first biosimilar recommended under its 'tailored clinical approach' — a framework that can let analytics substitute for a dedicated efficacy trial, though what Pebrilzo's own submission actually contained isn't yet public (EMA, 18 Sep 2026)
On 18 September 2026 the EMA's CHMP recommended Pebrilzo (pertuzumab) for breast cancer, stating it 'is the first biosimilar medicine recommended for…
A third indication built on a surrogate the FDA has already leaned on once — Kerendia is now approved for kidney disease in type 1 diabetes on a UACR reduction, not a measured drop in kidney failure or death (Bayer/FDA, 17 Sep 2026)
Bayer announced, in a release last updated 17 September 2026, that the FDA approved Kerendia (finerenone) to reduce UACR in adults with CKD and type …
A one-time infusion, not a chronic therapy — the FDA approved the first treatment of any kind for Sanfilippo syndrome type A, a single AAV9 gene therapy measured against an untreated historical cohort (FDA, 17 Sep 2026)
The FDA approved Fayuvi (rebisufligene etisparvovec-hopf) on 17 September 2026 as the first treatment for pediatric MPS IIIA (Sanfilippo syndrome typ…
An approval for children whose published pediatric evidence is safety and pharmacokinetics — the FDA extended Joenja (leniolisib) to 4-to-11-year-olds with APDS on a single-arm study of eight patients (FDA, 11 Sep 2026)
On 11 September 2026 the FDA approved Joenja (leniolisib) as 'the first treatment' for activated PI3K delta syndrome in children 4-11 weighing at lea…
The platform is becoming the creator's bank — Roblox will pay opted-in US independent creators aged 18+ every business day in US dollars through Roblox Wallet from December 2026, and transition away from DevEx in mid-2027 in the US (Roblox, 11 Sep 2026)
Roblox announced Roblox Wallet on 11 September 2026: from December 2026, US-based independent creators aged 18+ can opt in to be paid 'automatically …
A lab is routing its own flagship into the smallest model of its new family — DeepSeek says V4.1-Flash beats V4-Pro on performance, cost, speed and runtime, and from 14 September sends all V4-Pro traffic to it at Flash rates until V4.1-Pro launches (DeepSeek, 10 Sep 2026) [CORRECTED 15 Sep 2026 — the 14 September cutover did not happen; see the correction note at the foot of this card]
DeepSeek's own post of 10 September 2026 introduces V4.1-Flash, a 552B-parameter MoE using a 'Causal Encoder–Decoder architecture: just 8B active par…
The deprecation did not happen — DeepSeek's changelog and pricing page now say V4-Pro API service continues 'in response to user demand', while its own announcement page still says the traffic would be rerouted from 14 September (DeepSeek, read 15 Sep 2026)
DeepSeek said on 10 September 2026 it was 'phasing out V4-Pro' and would route all deepseek-v4-pro requests to V4.1-Flash from 04:00 UTC on 14 Septem…
The FDA extended sevabertinib's accelerated approval into untreated HER2 (ERBB2) TKD-mutant non-squamous NSCLC on an open-label, single-arm cohort of 69 patients, ORR 75% (95% CI: 64, 85) (FDA, 9 Sep 2026)
On 9 September 2026 the FDA granted accelerated approval to sevabertinib (Hyrnuo, Bayer) for HER2 (ERBB2) TKD-mutant non-squamous NSCLC, expanding an…
A platform is testing buying down the price in someone else's shop — Roblox is extending its test of platform-funded discounts to creators' passes and developer products, paying creators on the undiscounted price, with no opt-out described (Roblox, 9 Sep 2026)
A Roblox announcement of 9 September 2026 extends its test of platform-funded discounts from avatar items to in-game passes and developer products: '…
The first Lp(a)-lowering outcomes trial reads out, and the biomarker does not translate — pelacarsen lowered Lp(a) but Lp(a)HORIZON did not meet its primary cardiovascular-events endpoint (Novartis, 4 Sep 2026)
Novartis announced 4 September 2026 that pelacarsen's Phase III Lp(a)HORIZON trial — 8,323 patients, the first cardiovascular-outcomes readout for an…
FDA approved the first drug for Alexander disease — an antisense oligonucleotide cleared on 49 patients, with the under-2 indication carried by pharmacokinetic modelling plus four infants' safety data rather than a controlled trial (FDA press announcement, 3 Sep 2026)
On 3 September 2026 the FDA approved Zanvastro (zilganersen), an intrathecal antisense oligonucleotide, as the first treatment for Alexander disease,…
OpenAI released GPT-6 Astra, which it says is its first model at the 'Critical' cybersecurity level of its Preparedness Framework — and reported in the same document that the model's chain-of-thought monitorability has decreased (OpenAI, 3 Sep 2026)
OpenAI's 3 September 2026 safety overview states GPT-6 Astra 'is our first model to reach the Critical level of cybersecurity capability under our Pr…
Broadcom's AI semiconductor revenue reached $16.7bn, up 221%, with a $21.7bn fourth-quarter guide — the cabinet's second vendor-side quarterly receipt for the buildout, this time with cash flow above net income (8-K exhibit, 2 Sep 2026)
Broadcom's Q3 FY2026 release, furnished as an 8-K exhibit dated 2 September 2026, reports revenue of $29.6 billion, up 86%, with AI semiconductor rev…
Google shipped its third Flash model in six weeks, kept the introductory price, and printed the date it doubles — with a gated 'Flash Cyber' variant for vetted defenders (Google, 2 Sep 2026)
Google's post dated 2 September 2026 introduces Gemini 3.8 Flash 'three weeks' after 3.7 Flash, 'marking our third Flash release in only six weeks,' …
OpenAI says ChatGPT Ads reached a $1 billion annualized run rate in under 200 days, and opened self-serve buying across India, Europe, MEA — company-stated (OpenAI, 31 Aug 2026)
OpenAI's post dated 31 August 2026 states ChatGPT Ads reached '$1 billion in annualized revenue run rate' in 'less than 200 days after launch', with …
SHEIN's Hong Kong offering priced at HK$48.56 — below the maximum, 5.63× retail, HK$13.2bn net — with dealings expected 1 September (HKEX filing, 31 Aug 2026)
SHEIN priced its Hong Kong global offering at HK$48.56 per share — below the HK$49.50 maximum — in its final offer price and allotment results announ…
ACACIA-HCM: aficamten met both primary endpoints in non-obstructive hypertrophic cardiomyopathy — but the between-arm differences are 3.0 KCCQ points and 0.67 mL/kg/min, with a 10% versus 1% rate of ejection fraction below 50% (ESC Congress, 28 Aug 2026)
The ESC's press release of 28 August 2026 reports ACACIA-HCM, a double-blind phase III trial at 182 sites randomising 517 adults with symptomatic non…
The largest ATTR-CM trial ever run silenced the protein and missed its endpoint — eplontersen at rate ratio 0.89 (95% CI 0.73–1.09, p=0.277) in 1,432 patients, a non-significant result rather than a demonstrated null (ESC Congress press release, 28 Aug 2026)
CARDIO-TTRansform, a double-blind phase III trial in 130 centres across 20 countries, randomised 1,432 patients with transthyretin amyloid cardiomyop…
A hepcidin mimetic cleared FDA approval for polycythemia vera on a randomized placebo-controlled phlebotomy endpoint — 76.9% versus 32.9% (FDA, 28 Aug 2026)
On 28 August 2026 the FDA approved Mimrylo (rusfertide, Takeda), which the agency calls the first approved polycythemia vera treatment that mimics he…
USDA deregulated a genetically engineered forest tree — Darling 54 American chestnut, blight-tolerant, six years and seven months after the petition, and with the environmental impact statement abandoned (APHIS, 28 Aug 2026)
On 28 August 2026 USDA APHIS determined that Darling 54 American chestnut, engineered by SUNY ESF for tolerance to the blight fungus Cryphonectria pa…
The FDA approved an oral JAK/TYK2 inhibitor for dermatomyositis — direction reported, magnitude not disclosed in the announcement (FDA, 27 Aug 2026)
On 27 August 2026 the FDA approved Lisraya (brepocitinib, Priovant Therapeutics), a once-daily oral JAK/TYK2 inhibitor the agency calls the first FDA…
A once-daily RAS GTPase-family inhibitor cleared FDA approval for metastatic pancreatic cancer on a randomized overall-survival result — median 13.2 months versus 6.7 (FDA, 26 Aug 2026)
On 26 August 2026 the FDA approved daraxonrasib (RASONQUE, Revolution Medicines), an inhibitor of the RAS GTPase family, for adults with metastatic p…
NVIDIA reported a $96.2bn quarter — up 106% — guided to $108bn assuming zero China data-center compute, and announced platforms to mobilize over $500bn of third-party capital (8-K exhibit, 26 Aug 2026)
NVIDIA's Q2 FY2027 release, dated 26 August 2026, reports quarterly revenue of $96.2 billion, up 106% year over year, Data Center revenue of $89.0 bi…
Continuous ketone measurement got an FDA classification — a De Novo authorization for 'devices of a new type', with special controls, for diabetes and not for anything else (FDA, 25 Aug 2026)
On 25 August 2026 the FDA authorized Abbott's Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 and older with diab…
A fast-fashion growth engine went to 1.1% and posted a quarterly loss — in its own Hong Kong listing prospectus (SHEIN, 24 Aug 2026)
SHEIN Global Holdings' Hong Kong offering document, dated 24 August 2026, reports net revenue growth of 41.1% (2023), 20.7% (2024), 8.0% (2025) and 1…
MCP's maintainers published a new roadmap naming agent identity as a priority — and confirmed that sessions and the initialization handshake are gone from the shipped spec (Model Context Protocol, 22 Aug 2026)
On 22 August 2026 the Model Context Protocol's lead maintainers published 'The New MCP Roadmap', replacing the March 2026 roadmap with five priority …
The standard that protects steel in concrete may be the thing blocking low-carbon cement — ETH modelling finds local climate, not mix design, dominates corrosion rate (Nature Communications, 21 Aug 2026)
A peer-reviewed Nature Communications paper (DOI 10.1038/s41467-026-76916-3, 21 August 2026) argues that the durability paradigm protecting concrete …
The aging clocks were finally graded on whether they move — 51 intervention studies, 16 clocks, and a recommendation to prioritise two of them (Nature Medicine, 21 Aug 2026)
Higgins-Chen and colleagues published TranslAGE in Nature Medicine on 21 August 2026 — a harmonised database of 51 longitudinal intervention studies …
FDA granted accelerated approval to an oncolytic viral therapy for anti-PD-1-refractory melanoma — Tudriqev plus nivolumab, on a 91-patient single-arm response rate (FDA, 6 Aug 2026)
On 6 August 2026 the FDA granted accelerated approval to vusolimogene oderparepvec-wtpg (Tudriqev, Replimune), a genetically modified oncolytic viral…
The resale incumbent is buying provenance and selling attention — eBay's Q2 exhibit puts advertising at $596m on 2.7% of GMV and the Depop price at $1.4bn paid against $1.2bn announced (eBay, 5 Aug 2026)
eBay's Q2 2026 earnings exhibit, dated 5 August 2026, reports revenue of $3.134bn 'up 15% on an as-reported basis' and GMV of $22.398bn 'up 15%'. Adv…
A marketplace built on human-made goods named agent-readability as a reason for its discovery spend — and attached no number to it (Etsy, 5 Aug 2026)
Etsy's Q2 2026 shareholder letter, dated 5 August 2026, states that its investments in inventory signals, content feeds and product listing ad struct…
USDA deregulated a corn engineered for resistance to four herbicides, plus a fifth trait for seed production — MON 87429, just over six years after the petition notice (APHIS, 4 Aug 2026)
On 4 August 2026 USDA's Animal and Plant Health Inspection Service deregulated Monsanto's MON 87429 corn, engineered for resistance to dicamba, glufo…
eBay completed its acquisition of Depop, folding a Gen-Z C2C resale marketplace into a 'more than $10 billion annual GMV' fashion category (eBay, 30 Jul 2026)
eBay announced on 30 July 2026 that it has completed its acquisition of Depop, the Gen-Z consumer-to-consumer fashion resale marketplace the release …
Reddit is monetising human-written text through advertising, not licensing — Q2 2026: ad revenue $762m (+64%), all other revenue $43m (+24%) (SEC filing, 30 Jul 2026)
Reddit's Q2 2026 results, filed 30 July 2026, show revenue of $805 million, up 61%, with advertising at $762 million, up 64%, and all other revenue a…
FDA scheduled an advisory committee on a resubmitted RP1 BLA — Replimune's RP1 plus nivolumab in advanced melanoma, panel set for 30 July 2026 (SEC filing, 30 Jul 2026)
Replimune's Form 8-K, dated 30 July 2026, states that the company 'will attend a meeting' with the FDA's Cellular, Tissue, and Gene Therapies Advisor…
The AI buildout has not universally crossed over to the capital markets — Microsoft's FY2026 cash capex of $115.9bn sat inside $182.9bn of operating cash flow, with a $678bn contracted commercial book behind it (SEC filing, 29 Jul 2026)
Microsoft's FY2026 results, filed 29 July 2026, show full-year cash capital expenditure of $115.9 billion against $182.9 billion of operating cash fl…
The EU amended its own AI Act — Regulation (EU) 2026/1744, the 'Digital Omnibus on AI', entered into force 27 July 2026
Regulation (EU) 2026/1744, the Digital Omnibus on AI, entered into force on 27 July 2026. Dated 8 July 2026, it amends the AI Act (Regulation (EU) 20…
Europe's medicines committee recommended three new cholesterol drugs in one sitting — including obicetrapib, the first CETP inhibitor to get a positive CHMP opinion (24 Jul 2026)
On 24 July 2026 the EMA's CHMP published its July meeting highlights: twelve new medicines recommended for approval, including three for primary hype…
The AI buildout crossed over to the capital markets — Alphabet's Q2 2026 capex ($44.9bn) exceeded its operating cash flow, putting free cash flow at negative $5.9bn (SEC filing, 22 Jul 2026)
Alphabet's Q2 2026 results, filed 22 July 2026, show quarterly capital expenditure of $44.9 billion against $39.1 billion of operating cash flow — fr…
Paid search is compounding through the AI-answers transition while the open web stalls — Google Search & other +17% to $63.3bn, Google Network −0.7% (SEC filing, 22 Jul 2026)
Alphabet's filed Q2 2026 numbers separate the owned search funnel from the open web: Google Search & other rose 17% to $63.27 billion and YouTube ads…
A blood proteome panel distinguishes Alzheimer's, Lewy body and frontotemporal dementia — Nature Aging (20 Jul 2026)
A multicenter study in Nature Aging (20 Jul 2026) analyzed 1,318 plasma samples across Alzheimer's disease, dementia with Lewy bodies and frontotempo…
France's competition authority: three firms hold >84% of the AI-agents market — Autorité de la concurrence Opinion 26-A-05 (17 Jul 2026)
On 17 July 2026 France's Autorité de la concurrence published Opinion 26-A-05 on the AI-agents (agentic AI) sector, finding OpenAI, Google and Anthro…
GameStop discloses a ~9.8% eBay stake and escalates its takeover pursuit — SEC Form 425 (disclosed 17 Jul 2026)
On Friday 17 July 2026 GameStop disclosed it directly owns 43,390,383 eBay shares (~9.8%), up sharply from a ~5% economic stake in early May, after s…
LLNL/Pacific Fusion's SIRIUS pulsed-power prototype passes 3,000 shots at 95% efficiency — LLNL (write-up 16 Jul 2026)
Lawrence Livermore National Laboratory and Pacific Fusion report their four-stage SIRIUS prototype — an impedance-matched Marx generator — has surpas…
FDA approves enlicitide (Merck's LIPFENDRA) — the first oral PCSK9 inhibitor for lowering LDL-C (16 Jul 2026)
On 16 July 2026 the U.S. FDA approved Merck's enlicitide decanoate (brand LIPFENDRA; code MK-0616) — the first oral PCSK9 inhibitor, a once-daily 20 …
Visa launches an enterprise Stablecoin Platform (VSP), opening with Open USD — Visa newsroom (16 Jul 2026)
On 16 July 2026 Visa announced the Visa Stablecoin Platform (VSP): a single Visa-managed environment for banks, fintechs and crypto-natives to mint, …
Inkling: a 975B open MoE built to be fine-tuned, not to top leaderboards
Thinking Machines Lab (founded by ex-OpenAI CTO Mira Murati) released Inkling on 2026-07-15: a 975B-parameter mixture-of-experts model (41B active pe…
A 'FINRA for frontier AI' — Hassabis proposes verification as the US deployment gate
In a signed essay (Jul 14, 2026), Google DeepMind CEO Demis Hassabis calls for a US-led, federally-overseen Frontier AI Standards Body modeled on FIN…
Weco AI reports 'Level 1' harness-only recursive self-improvement — a real bounded result, softer than the headline
Weco AI's first-party report says its AIDE² outer loop autonomously rewrote the harness/scaffolding of an inner ML-research agent for 100 consecutive…
x402 Foundation goes operational — Coinbase contribution complete, 40 members on board (Linux Foundation, 14 Jul 2026)
On 14 July 2026 the Linux Foundation announced the operational launch of the x402 Foundation and the completed contribution of the x402 protocol by C…
US reportedly weighing an open-weight model 'ceiling' pegged to China's leading open model (WaPo scoop, talks only)
The Washington Post's AI & Tech Brief reported — a single-source scoop, NOT corroborated by the FT — that the Trump administration and AI-industry gr…
Apple sues OpenAI, io Products, and ex-Apple hardware chief over hardware trade secrets (DTSA + breach of contract)
On 2026-07-10 Apple filed a complaint (Apple Inc. v. Chang Liu, No. 5:26-cv-07078, N.D. Cal.) accusing OpenAI (OpenAI Foundation f/k/a OpenAI, Inc. a…
Micron breaks ground on ~¥1.5T (~$9.3B) DRAM/HBM cleanroom expansion in Hiroshima
On 2026-07-04 Micron broke ground on a new cleanroom at its Higashi-Hiroshima fab to scale advanced 1-gamma DRAM and HBM for AI memory, backed by up …
China quant-fund AUM estimated above ¥2.6T as quant strategies beat discretionary managers by ~20 points
Bloomberg (2026-07-02) reports China quant funds' AUM more than doubled in under a year to over ¥2.6T, with long-only stock quants returning 44.7% in…
Third US microreactor reaches initial criticality under DOE, meeting Trump's July-4 deadline (a fourth followed)
Per the DOE (July 1, 2026), Deployable Energy's Unity completed a 'zero-power fueled criticality demonstration' at Idaho National Laboratory late Jun…
FDA put seven grey-market longevity peptides through formal review — a Pharmacy Compounding Advisory Committee sitting on 23–24 July 2026 (held at signal)
FDA published the agenda and full briefing documents for a Pharmacy Compounding Advisory Committee meeting on 23–24 July 2026 weighing seven peptides…
Police drones cross a price/authority threshold as the US squeezes foreign-made models
Orlando PD activated an 11-drone Skydio X10 DFR network on June 17, 2026 — nine rooftop docks, ~$759k/yr for the first nine years inside a council-ap…
Swiss Parliament votes to lift the new-nuclear ban (June 2026) — referendum pending, voters likely decide in 2027
On 18 June 2026 both chambers of the Swiss Parliament gave final approval to an indirect counter-proposal amending the Nuclear Energy Act (KEG) that …
Helion secures the world's first regulatory licenses (radioactive materials + air emissions) for a fusion power plant
On 2026-06-16 the Washington State Dept. of Health granted Helion a Radioactive Materials License (RML) and a Radioactive Air Emissions License (RAEL…
SK Group chairman: HBM/memory is the AI buildout's binding constraint, with the shortage forecast to run to ~2030
At Computex on 2 June 2026, SK Group chairman Chey Tae-won (not a separately-quoted SK Hynix CEO) said the AI-driven memory/HBM shortage will likely …
Q1 2026 was a record robotics/physical-AI VC quarter ($16.3B across 492 deals) per PitchBook; relayed by a16z
PitchBook's Q1 2026 Robotics & Physical AI VC Trends report (published May 2026) found the sector had its strongest quarter on record, with $16.3B ra…
Mercedes-Benz partners with Liquid AI to run non-transformer LFMs on-device in North American MBUX cars
Mercedes-Benz and Liquid AI announced a multi-year partnership (2026-04-23) to run embedded Liquid Foundation Models on-device — fast, private, no cl…
Frontier models are now the least transparent — labs stopped disclosing training compute, data, and parameters (Stanford AI Index 2026)
Stanford HAI's AI Index 2026 finds industry produced over 90% of notable AI models in 2025, yet 'the most capable models are now the least transparen…
Unitree R1 humanoid launched at US$5,900; R1 AIR tier now sells from US$4,900
Unitree unveiled the R1 humanoid on 25 Jul 2025 at 39,999 yuan (~US$5,900); a cheaper R1 AIR tier at US$4,900 was added around March 2026, and both p…
Fusion sector baseline: 53 firms, $9.766B cumulative (FIA Global Fusion Industry Report 2025)
The Fusion Industry Association's fifth annual Global Fusion Industry Report (released 22 July 2025) surveyed 53 fusion companies whose cumulative fu…
BIS rescinded the AI Diffusion Rule (May 13, 2025) — model weights were briefly codified as a controlled export (ECCN 4E091), but the control was never enforced
On May 13, 2025, Commerce/BIS announced the rescission of the Biden Administration's AI Diffusion Rule (issued January 15, 2025) and instructed enfor…
Open Athena — engineers and compute for open academic foundation models
Open Athena, a 501(c)(3) nonprofit founded in 2024 by Jeff Hammerbacher (Founder/CEO) and David Siegel (Founder/Chairman, who separately co-founded T…
Internal-first and gated. Primary sources only for anything marked "verified"; every card carries a freshness date and a falsifier; hype is labelled hype. Nothing here diverts engineering from the BKG paying-customer P0 — this is analytic/spec time, not engineering time. Any tool that emerges starts as a stub/spec. Claude stages + validates; the founder commits, builds (npm run build), and deploys locally. A card is not "live" until built and deployed.